Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung-Wai Shiau

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|September 29, 2018
Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1Jung-Chen Su, Chuan-Hsun Chang, Szu-Hsien Wu, et al.
The Journal of Biological Chemistry|January 15, 2005
Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stressOlivia S Gardner, Chung-Wai Shiau, Ching-Shih Chen, et al.
World Journal of Gastroenterology|November 12, 2014
Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapyMan-Hsin Hung, Wei-Tien Tai, Chung-Wai Shiau, et al.
International Journal of Molecular Sciences|June 9, 2017
Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer TherapyTzu-Ting Huang, Jung-Chen Su, Chun-Yu Liu, et al.
Molecular Cancer Therapeutics|June 21, 2008
Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteinsDayong Zhai, Chaofang Jin, Chung-Wai Shiau, et al.
Molecules (Basel, Switzerland)|December 23, 2017
Design and Synthesis of Malonamide Derivatives as Antibiotics against Methicillin-Resistant Staphylococcus aureusJung-Chen Su, Yu-Ting Huang, Chang-Shi Chen, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 26, 2023
Repurposing the tyrosine kinase inhibitor nilotinib for use against intracellular multidrug-resistant Salmonella TyphimuriumShih-Hsiu Chou, Tsai-Wen Wan, Chung-Wai Shiau, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 27, 2019
Loxapine, an antipsychotic drug, suppresses intracellular multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium in macrophagesChing-Yi Yang, Cheng-Yun Hsu, Chun-Sheng Fang, et al.
The Journal of Biological Chemistry|May 17, 2013
Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activationHui-Chuan Yu, Chen-Si Lin, Wei-Tien Tai, et al.
Breast Cancer Research : BCR|April 28, 2012
CIP2A is a target of bortezomib in human triple negative breast cancer cellsLing-Ming Tseng, Chun-Yu Liu, Kung-Chi Chang, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Journal of Enzyme Inhibition and Medicinal Chemistry|September 29, 2018
Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1Jung-Chen Su, Chuan-Hsun Chang, Szu-Hsien Wu, et al.
The Journal of Biological Chemistry|January 15, 2005
Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stressOlivia S Gardner, Chung-Wai Shiau, Ching-Shih Chen, et al.
World Journal of Gastroenterology|November 12, 2014
Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapyMan-Hsin Hung, Wei-Tien Tai, Chung-Wai Shiau, et al.
International Journal of Molecular Sciences|June 9, 2017
Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer TherapyTzu-Ting Huang, Jung-Chen Su, Chun-Yu Liu, et al.
Molecular Cancer Therapeutics|June 21, 2008
Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteinsDayong Zhai, Chaofang Jin, Chung-Wai Shiau, et al.
Molecules (Basel, Switzerland)|December 23, 2017
Design and Synthesis of Malonamide Derivatives as Antibiotics against Methicillin-Resistant Staphylococcus aureusJung-Chen Su, Yu-Ting Huang, Chang-Shi Chen, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 26, 2023
Repurposing the tyrosine kinase inhibitor nilotinib for use against intracellular multidrug-resistant Salmonella TyphimuriumShih-Hsiu Chou, Tsai-Wen Wan, Chung-Wai Shiau, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 27, 2019
Loxapine, an antipsychotic drug, suppresses intracellular multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium in macrophagesChing-Yi Yang, Cheng-Yun Hsu, Chun-Sheng Fang, et al.
The Journal of Biological Chemistry|May 17, 2013
Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activationHui-Chuan Yu, Chen-Si Lin, Wei-Tien Tai, et al.
Breast Cancer Research : BCR|April 28, 2012
CIP2A is a target of bortezomib in human triple negative breast cancer cellsLing-Ming Tseng, Chun-Yu Liu, Kung-Chi Chang, et al.
Pageof 10